Hyperparathyroidism Secondary
Mostrando 1-12 de 83 artigos, teses e dissertações.
-
1. Normocalcemic primary hyperparathyroidism
ABSTRACT Normocalcemic primary hyperparathyroidism (PHPT) is a newer phenotype of PHPT defined by elevated PTH concentrations in the setting of normal serum calcium levels. It is increasingly being diagnosed in the setting of evaluation for nephrolithiasis or metabolic bone diseases. It is important to demonstrate that PTH values remain consistently elevated
Archives of Endocrinology and Metabolism. Publicado em: 2022
-
2. Vitamin D metabolism and extraskeletal outcomes: an update
ABSTRACT Vitamin D deficiency is a general health problem affecting individuals at all stages of life and on different continents. The musculoskeletal effects of vitamin D are well known. Its deficiency causes rickets, osteomalacia, and secondary hyperparathyroidism and increases the risk of fractures. Clinical and experimental evidence suggests that vitamin
Archives of Endocrinology and Metabolism. Publicado em: 2022
-
3. Fibrous osteodystrophy due to secondary renal hyperparathyroidism in a senile dog
RESUMO O hiperparatireoidismo renal destaca-se entre as complicações da doença renal em cães, pela retenção de fósforo com predisposição à hipocalcemia, estimulação de paratormônio com mobilização do cálcio dos ossos, caracterizando a osteodistrofia fibrosa, incomum em idosos. O objetivo foi relatá-la em Labrador de 12 anos com poliúria, po
Arquivo Brasileiro de Medicina Veterinária e Zootecnia. Publicado em: 2022
-
4. Celiac disease and bone
Abstract Celiac disease (CD) is an autoimmune disorder characterized by small intestinal inflammation triggered by gluten ingestion in genetically-predisposed individuals. A frequent extra-intestinal manifestation of CD is metabolic bone disease which contributes to an increased risk of fracture. The mechanisms underlying bone disease in CD remain incomplete
Archives of Endocrinology and Metabolism. Publicado em: 2022
-
5. Parathyroid hormone levels after parathyroidectomy for secondary hyperparathyroidism
SUMMARY OBJECTIVE: The parathormone level after parathyroidectomy in dialysis patients are of interest. Low levels may require cryopreserved tissue implantation; however, the resection is necessary in case of recurrence. We analyzed post parathyroidectomy parathormone levels in renal hyperparathyroidism. METHODS: Prospective observation of postoperative pa
Rev. Assoc. Med. Bras.. Publicado em: 2021-02
-
6. Reasons to avoid vitamin D deficiency during COVID-19 pandemic
ABSTRACT The effects of vitamin D on the musculoskeletal system are well established. Its deficiency causes osteomalacia, secondary hyperparathyroidism, and an increased risk for fractures and falls. However, clinical and experimental evidence points to extra-skeletal actions of vitamin D, including on immune and respiratory systems. Thus, during this COVID-
Arch. Endocrinol. Metab.. Publicado em: 2020-10
-
7. Reference values of 25-hydroxyvitamin D revisited: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC)
ABSTRACT Hypovitaminosis D is a common condition with a negative impact on health. This statement, prepared by experts from the Brazilian Society of Endocrinology and Metabolism and the Brazilian Society of Clinical Pathology/Laboratory Medicine, includes methodological aspects and limitations of the measurement of 25-hydroxyvitamin D [25(OH)D] for identific
Arch. Endocrinol. Metab.. Publicado em: 2020-08
-
8. The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
Resumo Introdução: O tratamento do hiperparatireoidismo secundário (HPTs), patologia comum e associada à mortalidade na doença renal crônica, é um desafio para o nefrologista. Advento dos calcimiméticos propiciou terapêutica medicamentosa diferente da usual, baseada em quelantes de fósforo e vitamina D ativa. O objetivo deste estudo foi avaliar se
J. Bras. Nefrol.. Publicado em: 18/07/2019
-
9. Differences in the prevalence of vitamin D deficiency and hip fractures in nursing home residents and independently living elderly
ABSTRACT Objective To compare the prevalence of vitamin D deficiency and fracture history in nursing home residents and community-dwelling elderly subjects and to explore the association of vitamin D levels with various characteristics. Materials and methods Sixty-six nursing home residents and 139 community-dwelling elderly subjects participated. Marital
Arch. Endocrinol. Metab.. Publicado em: 23/02/2016
-
10. Is Primary Hyperparathyroidism a Risk Factor for Papillary Thyroid Cancer? An Exemplar Study and Literature Review
Introduction Primary hyperparathyroidism (PHPT) is associated with several cancer types, including papillary thyroid carcinoma (PTC). Objective To explore further the relation between PHPT and PTC.
Methods By considering patients with PHPT as extra-suspicious for PTC, we studied an exemplar group of pati
Int. Arch. Otorhinolaryngol.. Publicado em: 2015-03
-
11. Fatores preditivos da hipofunção do autoimplante de paratireóide em pacientes submetidos à paratireoidectomia total por hiperparatireoidismo secundário à insuficiência renal crônica / redictive factors of parathyroid auto-implant hypofunction in patients with chronic kidney disease submitted to totalparathyroidectomy due to secondary hyperparathyroidism
O hiperparatireoidismo (HPT) secundário é uma complicação da doença renal crônica. A paratireoidectomia total com autoimplante proporciona bons resultados no seu tratamento, mas alguns doentes não desenvolvem níveis adequados de hormônio da paratireóide (PTH) após a operação. Os objetivos, do presente estudo, foram analisar fatores que poderiam
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 06/11/2012
-
12. Efeito da associação do carbonato de magnésio com acetato de cálcio (OSVAREN®) no controle do fósforo, no hiperparatireoidismo secundário e no remodelamento ósseo em ratos urêmicos / Magnesium carbonate/calcium acetate (Osvaren®) association effects in phosphorus, secondary hyperparathyroidism and bone turnover in uremic rats
Introdução: O quelante de fósforo (P) Osvaren® foi lançado recentemente no mercado internacional para tratamento da hiperfosfatemia nos pacientes com Doença Renal Crônica (DRC). Não existem estudos experimentais com esta medicação. Objetivo: Avaliar a ação deste quelante no tratamento do Distúrbio Mineral e Ósseo (DMO) de ratos com DRC induzida
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 27/07/2012